Ampio Pharmaceuticals (NYSE:AMPE) Now Covered by StockNews.com

StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPEFree Report) in a research note released on Friday morning. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Price Performance

Shares of AMPE remained flat at $0.00 during midday trading on Friday. 4,702 shares of the stock traded hands, compared to its average volume of 66,601. Ampio Pharmaceuticals has a one year low of $0.00 and a one year high of $7.47. The company has a market cap of $2,508.00, a P/E ratio of 0.00 and a beta of 3.73.

About Ampio Pharmaceuticals

(Get Free Report)

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.

See Also

Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.